Showing results (291-300 of 346) with videos related to

Sort By:
Pageof 35
Critical Care Medicine|February 22, 2007
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemiaAndrew F Shorr, D Ray Lazarus, John H Sherner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2013
Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitalsAndrew F Shorr, Marya D Zilberberg, Richard Reichley, et al.
Pharmacotherapy|March 26, 2010
Hospital resource utilization and costs of inappropriate treatment of candidemiaHeather M Arnold, Scott T Micek, Andrew F Shorr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trialAndrew F Shorr, Neringa Zadeikis, William L Jackson, et al.
Surgical Infections|March 6, 2010
Bacteremia increases the risk of death among patients with soft-tissue infectionsScott T Micek, Alex P Hoban, Victor Pham, et al.
Critical Care (London, England)|October 16, 2021
Timing of antibiotic therapy in the ICUMarin H Kollef, Andrew F Shorr, Matteo Bassetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2011
Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency departmentAndrew F Shorr, Marya D Zilberberg, Richard Reichley, et al.
Respiratory Medicine|October 8, 2005
Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung diseaseChristopher J Lettieri, Ganesh R Veerappan, Joseph M Parker, et al.
Surgical Infections|May 8, 2014
Macrolides are associated with a better survival rate in patients hospitalized with community-acquired but not healthcare-associated pneumoniaColleen McEvoy, Scott T Micek, Richard M Reichley, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjectsKelly A Sprandel, Christopher A Schriever, Susan L Pendland, et al.
Pageof 35